Skip to main content

Frances Murphy

Frances Murphy, co-head of the pharmaceuticals, biotechnology and healthcare group of Slaughter and May, has been named to head the international law firm’s flagship corporate team, effective May 1. Murphy will succeed Chris Saul, who has been named a senior partner.
Murphy joined Slaughter and May in 1981, and became a partner in 1990. Among deals she has been involved with in recent years include advising BAE on its acquisition of Alvis, and advising General Electric on the acquisition of Smiths Group Aerospace and a detection joint venture with Smiths Group.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.